Regulation & law · 17/09/1996Updated: 10/18/2026 · 1 min read

NIH Announces Intercompany Collaboration to Develop New AIDS Drugs

Summary

The National Institutes of Health (NIH) has announced an intercompany collaboration to accelerate the development of new AIDS drugs, pursuant to the National Cooperative Research and Production Act of 1993. The initiative aims to leverage the collective expertise of pharmaceutical companies to bring innovative treatments to market more quickly.

Original source language: Federal Register — Justice DepartmentOpen original release →

Add your company to Business Communicator

We monitor business sources and connect attention with companies, profiles and services available in Business Communicator.

Create a free company profile Explore businesses on Business Maps →

Create a free company profile →

Explore insights

Business insights →

Healthcare Business News Global Markets News Trade Regulation News Business Technology News Fintech for Business: Payments & Banking News Supply Chain News

Related business signals

Regulation & law · 9/2/2026

Department of Justice to Reestablish Global Justice Information Sharing Initiative Advisory Committee

The Department of Justice plans to file a charter for the reestablishment of the Global Justice Information Sharing Initiative Advisory Committee (GAC), a federal advisory committee, to provide recommendations on national justice information and criminal intelligence sharing policy. The GAC will support improved public safety and coordination among federal, state, local, tribal, territorial, and other justice-interested partners.

Read summary →

Regulation & law · 9/14/2026

Bulk Manufacturer of Controlled Substances Application: Cambrex High Point, Inc.

Cambrex High Point, Inc. has submitted an application to the U.S. government to be registered as a bulk manufacturer of controlled substances, a key step in the production and distribution of certain medications. The company is seeking to manufacture basic classes of controlled substances, as outlined in the accompanying SUPPLEMENTARY INFORMATION.

Read summary →

Regulation & law · 9/11/2026

Bureau of Justice Statistics Requests OMB Approval for 2026 National Survey of Victim Service Providers

The Bureau of Justice Statistics is seeking OMB approval to reinstate and modify a previously approved information collection, the 2026 National Survey of Victim Service Providers, which has expired.

Read summary →

Regulation & law · 9/8/2026

Fresenius Kabi USA, LLC Seeks Registration as Controlled Substance Importer

Fresenius Kabi USA, LLC has submitted an application to the U.S. government to be registered as an importer of controlled substances, including basic classes of medications. The company aims to import these controlled substances for distribution in the United States.

Read summary →

Regulation & law · 9/4/2026

US Government Proposes Final Judgment Against KKR & Co. Inc. and Other Companies

The US government has proposed a final judgment against KKR & Co. Inc. and other companies, alleging antitrust violations. The proposed judgment aims to address competitive concerns related to the companies' business practices.

Read summary →